← MYRIAD GENETICS INC MYGN
Market Price
$3.03
Market Cap
$298.46M
P/E Ratio
N/A
Revenue (FY 2025)
↓-1.6% YoY
$824.50M
3-Yr CAGR: 6.7%
Net Income
↓-187.4% YoY
-$365.90M
Net Margin: -44.4%
Free Cash Flow
↑33.3% YoY
-$25.60M
FCF Yield: -8.58%
EPS (Diluted)
↓-180.1% YoY
$-3.95
Basic: $-3.95
Return on Equity
Efficiency
-99.4%
ROA: -1,457.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MYGN)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2020: Revenue YoY (-25.0%) is identical to Gross Profit YoY (-25.0%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
- FY 2021: Revenue YoY (+8.1%) is identical to Gross Profit YoY (+8.1%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
- FY 2022: Revenue YoY (-1.8%) is identical to Gross Profit YoY (-1.8%). Verify the underlying Revenue and Gross Profit values for FY 2022 and FY 2021.
- FY 2023: Revenue YoY (+11.0%) is identical to Gross Profit YoY (+11.0%). Verify the underlying Revenue and Gross Profit values for FY 2023 and FY 2022.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $753.8M | — | $621.0M | $125.3M | — | $1.71 | — | $166.3M | $161.3M | — |
| FY 2017 | $771.4M | +2.3% | $626.2M | $21.8M | -82.6% | $0.32 | -81.3% | $106.2M | $100.1M | -37.9% |
| FY 2018 | $772.6M | +0.2% | $118.7M | $131.1M | +501.4% | $1.82 | +468.8% | $115.9M | $107.5M | +7.4% |
| FY 2019 | $851.1M | +10.2% | $645.5M | $4.6M | -96.5% | $0.06 | -96.7% | $83.7M | $75.1M | -30.1% |
| FY 2020 | $638.6M | -25.0% | $484.4M | $-199.5M | -4,437.0% | $-2.69 | -4,583.3% | $60.7M | $52.8M | -29.7% |
| FY 2021 | $690.6M | +8.1% | $523.8M | $-27.2M | +86.4% | $-0.35 | +87.0% | $18.2M | $0.2M | -99.6% |
| FY 2022 | $678.4M | -1.8% | $514.5M | $-112.0M | -311.8% | $-1.39 | -297.1% | $-106.3M | $-151.6M | -75,900.0% |
| FY 2023 | $753.2M | +11.0% | $571.3M | $-263.3M | -135.1% | $-3.18 | -128.8% | $-110.9M | $-184.2M | -21.5% |
| FY 2024 | $837.6M | +11.2% | $585.4M | $-127.3M | +51.7% | $-1.41 | +55.7% | $-8.7M | $-38.4M | +79.2% |
| FY 2025 | $824.5M | -1.6% | $576.6M | $-365.9M | -187.4% | $-3.95 | -180.1% | $1.8M | $-25.6M | +33.3% |
Valuation
Market Price
$3.03
Market Cap
$298.46M
Enterprise Value
$268.76M
P/E Ratio
N/A
P/B Ratio
0.78
FCF Yield
-8.58%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
69.93%
Operating Margin
-46.96%
Net Margin
-44.38%
Return on Equity (ROE)
-99.43%
Return on Assets (ROA)
-1,457.77%
Asset Turnover
32.85x
Revenue 3-Yr CAGR
6.72%
Financial Health & Liquidity
Current Ratio
0.26
Cash Ratio
1.54
Debt / Equity
0.326
Debt / Assets
4.777
Cash & Equivalents
$149.60M
Total Debt
$119.90M
Book Value / Share
$3.90
Cash Flow Efficiency
Operating Cash Flow
$1.80M
Capital Expenditures (CapEx)
$27.40M
Free Cash Flow
-$25.60M
OCF / Revenue
0.22%
FCF / Revenue
-3.10%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-3.95
EPS (Basic)
$-3.95
Dividends / Share
N/A
Book Value / Share
$3.90
EPS YoY Growth
-180.14%
Balance Sheet (FY 2025)
Total Assets
$25.10M
Total Liabilities
$96.90M
Stockholders' Equity
$368.00M
Current Assets
$25.10M
Current Liabilities
$96.90M